These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18541718)

  • 1. Overlap between in vitro donor antihost and in vivo posttransplantation TCR Vbeta use: a new paradigm for designer allogeneic blood and marrow transplantation.
    Friedman TM; Goldgirsh K; Berger SA; Zilberberg J; Filicko-O'Hara J; Flomenberg N; Donato M; Rowley SD; Korngold R
    Blood; 2008 Oct; 112(8):3517-25. PubMed ID: 18541718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling graft-versus-host disease and graft-versus-leukemia responses using TCR Vβ spectratype analysis in a murine bone marrow transplantation model.
    Fanning SL; Zilberberg J; Stein J; Vazzana K; Berger SA; Korngold R; Friedman TM
    J Immunol; 2013 Jan; 190(1):447-57. PubMed ID: 23203931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
    Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infusion of select leukemia-reactive TCR Vbeta+ T cells provides graft-versus-leukemia responses with minimization of graft-versus-host disease following murine hematopoietic stem cell transplantation.
    Patterson AE; Korngold R
    Biol Blood Marrow Transplant; 2001; 7(4):187-96. PubMed ID: 11349805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonmyeloablative conditioning allows for more rapid T-cell repertoire reconstitution following allogeneic matched unrelated bone marrow transplantation compared to myeloablative approaches.
    Friedman TM; Varadi G; Hopely DD; Filicko J; Wagner J; Ferber A; Martinez J; Brunner J; Grosso D; McGuire L; Korngold R; Flomenberg N
    Biol Blood Marrow Transplant; 2001; 7(12):656-64. PubMed ID: 11787528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion.
    Orsini E; Alyea EP; Schlossman R; Canning C; Soiffer RJ; Chillemi A; Neuberg D; Anderson KC; Ritz J
    Bone Marrow Transplant; 2000 Mar; 25(6):623-32. PubMed ID: 10734296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inter-strain tissue-infiltrating T cell responses to minor histocompatibility antigens involved in graft-versus-host disease as determined by Vbeta spectratype analysis.
    Zilberberg J; McElhaugh D; Gichuru LN; Korngold R; Friedman TM
    J Immunol; 2008 Apr; 180(8):5352-9. PubMed ID: 18390717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vbeta spectratype analysis reveals heterogeneity of CD4+ T-cell responses to minor histocompatibility antigens involved in graft-versus-host disease: correlations with epithelial tissue infiltrate.
    Friedman TM; Statton D; Jones SC; Berger MA; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2001; 7(1):2-13. PubMed ID: 11215694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune reconstitution and tolerance after allogeneic hematopoietic stem cell transplantation.
    Imamura M; Tsutsumi Y; Miura Y; Toubai T; Tanaka J
    Hematology; 2003 Feb; 8(1):19-26. PubMed ID: 12623423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of alphabeta- and gammadelta-T cells in allogenic donor marrow on engraftment, chimerism, and graft-versus-host disease.
    Huang Y; Cramer DE; Ray MB; Chilton PM; Que X; Ildstad ST
    Transplantation; 2001 Dec; 72(12):1907-14. PubMed ID: 11773887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo characterization of graft-versus-tumor responses in melanoma patients after allogeneic peripheral blood stem cell transplantation.
    Kurokawa T; Fischer K; Bertz H; Hoegerle S; Finke J; Mackensen A
    Int J Cancer; 2002 Sep; 101(1):52-60. PubMed ID: 12209588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct TCRAV and TCRBV repertoire and CDR3 sequence of T lymphocytes clonally expanded in blood and GVHD lesions after human allogeneic bone marrow transplantation.
    Hirokawa M; Matsutani T; Saitoh H; Ichikawa Y; Kawabata Y; Horiuchi T; Kitabayashi A; Yoshioka T; Tsuruta Y; Suzuki R; Miura AB; Sawada K
    Bone Marrow Transplant; 2002 Dec; 30(12):915-23. PubMed ID: 12476285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation.
    Dey BR; McAfee S; Colby C; Sackstein R; Saidman S; Tarbell N; Sachs DH; Sykes M; Spitzer TR
    Biol Blood Marrow Transplant; 2003 May; 9(5):320-9. PubMed ID: 12766882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for the identification of T cell-recognized tumor antigens in hematological malignancies for improved graft-versus-tumor responses after allogeneic blood and marrow transplantation.
    Zilberberg J; Feinman R; Korngold R
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1000-7. PubMed ID: 25459643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evidence for TCR Vbeta clonal expansion T cells in a patient with cGVHD after unrelated donor BMT].
    Du X; Li Y; Weng J; Lu Z; Su J; Lin W; Huang Z
    Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):406-8. PubMed ID: 11877011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infiltrating T cells during liver graft-versus-host disease show a restricted T-cell repertoire.
    Margolis DA; Casper JT; Segura AD; Janczak T; McOlash L; Fisher B; Miller K; Gorski J
    Biol Blood Marrow Transplant; 2000; 6(4):408-15. PubMed ID: 10917576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
    Edinger M; Hoffmann P; Ermann J; Drago K; Fathman CG; Strober S; Negrin RS
    Nat Med; 2003 Sep; 9(9):1144-50. PubMed ID: 12925844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell repertoire complexity after allogeneic bone marrow transplantation.
    Roux E; Helg C; Chapuis B; Jeannet M; Roosnek E
    Hum Immunol; 1996; 48(1-2):135-8. PubMed ID: 8824582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal analysis of T-cell receptor variable beta chain repertoire in patients with acute graft-versus-host disease after allogeneic stem cell transplantation.
    Liu C; He M; Rooney B; Kepler TB; Chao NJ
    Biol Blood Marrow Transplant; 2006 Mar; 12(3):335-45. PubMed ID: 16503503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.